Clinical Trial Update: Gamma-delta Tocotrienol as Potential Maintenance Treatment in Women With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update on gamma-delta tocotrienol as maintenance treatment in women with metastatic breast cancer, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gamma-delta Tocotrienol (gamma-delta tocotrienol)

Snippet

Sponsor: Malaysia Palm Oil Board | Conditions: Healthy Subjects | Phase 1 | Status: COMPLETED